Reneuron Share Discussion Threads

[norbus] 30/5/2017 09:21

The Japanese eat blow fish even though it can kill them; They love it. I wish to warn mugs not to get caught remains my interest. The regulators could not care less. Many laughed at Rocket Fuel. I hopw they can still do so. Why not ask Neil Woodford how he feels?

[fredd1eboy] 29/5/2017 19:27

If you've sold at 6.5p norbus, you should be a happy bunnie. I'm guessing you believe that you are looking after our interests in slagging off Micheal Hunt.
Personally I wouldn't trust you as far as I could throw you regarding looking after my interests. So why don't you concentrate on the stocks your actually invested in.
I'm not very happy with Reneurons current stock price and your comments don't really make me feel any better. So please back off for a while...preferably a long while or until you are actually invested in the company. Best wishes. Freddie

[norbus] 29/5/2017 17:59

Mike Hunt is shaking : with laughter all the way to the bank. He got rich while you miserable plebs lost your savings. Woodford likely fell for some yarns by Chris Evans.
Unless it is all a show till Woodford takes it private, something smells of a rat in the woodwork. Are you being told the truth? Where is the alternative treatments? If these people conned HM ER at £2 a share, why should mugs like you be spared? I left the ship at >6.5 p and glad I did so . A Wasp does not produce honey; It stings. Sad

[fredd1eboy] 26/5/2017 11:31

Facts.....Reneuron would probably not exist by now if it wasn't for Woodford and others investing heavily at 5p. Fund subscribers are probably far more out of pocket than us, so why not give Neil a break. Also, Micheal Hunt's professional stewardship has seen us thus far...and there's plenty of news to come. I also believe Olav is passionate about the company and probably his poor use of English humour as influenced by his native tongue has probably not helped him. Personally, I'm going to give everyone a break and allow them some breath to deliver. If by the next investor meeting we have not improved, I'm attending and I don't take prisoners when I speak my views.

[norbus] 26/5/2017 10:31

They are only cheap if you sell at a profit; The proposition is esoteric, management
has baggage. At best , Woodford & Co will steal the deal, At worst , Mike Hunt will live off what he has put away whist Rene incurred big losses ;

[audigger] 25/5/2017 22:59

Given where we are with respect to product lifecycle and how distant revenue streams are from proven treatments that are approved for clinical use it's hardly surprising that the share price hasnt taken off. Of course potential and sentiment could drive it higher but this is unlikely to happen until there is greater confidence that there will be end-products. They ain't going bust any time soon so if you believe load up whilst they are cheap.

[rotors] 25/5/2017 17:02

A raft of positive news + a substantial grant + an analyst target price of 15p = the stock now trading below its cash value. How does that work?

[volsung] 25/5/2017 16:30

Why would anyone buy these when they are constantly falling in value? Sensible to see an upturn in the chart before committing cash here.

[fredd1eboy] 25/5/2017 16:17

Strikes me the focus is 100% on the science at the expense of the commercial/business game plan.....The market needs credible evidence of potential gains which must be accompanied by excellent peer reviewed evidence of lasting efficacy and potential revenue streams and timing together and in conjunction with credible timing and excellent support from the media.
Sadly all too lacking of recent.

[taffyink] 25/5/2017 15:46

Half way through my holiday in Cyprus the stop loss kicked in at lunchtime. I still think this business is well founded, appears to be well run and with products that have potential. However, the market sellers think otherwise. I'm really sorry to be out
Best of liuck to all still in

[dickbush] 25/5/2017 14:24

1.90 bid and sellers happy to take it.

Taking into account the very positive performance of the overall market in recent months, there seems to be a distinct lack of belief in Rene's producing anything of value.

Michael Hunt is drinking in the Last Chance Saloon.

[norbus] 22/5/2017 15:23

For such positive news , this makes new lows; dread to think what if news bad? smelling like a fixed stich up

[audigger] 19/5/2017 11:52

Have taken the plunge! Whilst good communication from the company is appreciated, I prefer a much more hands-off approach focusing on key developments and milestones. The every day ebb & flow of bringing a new treatment to market is like riding a roller coaster! The potential here is huge, although its definitely a risky play. I look forward to the rewards!

[deutsch3] 19/5/2017 11:20

The big dump goes on!

[dogwalker] 18/5/2017 09:46

Good points, Hyper Al. Ongoing presentation & publication of research is vital after all. No worries about leakage to competitors at home or abroad etc. because of ...patents.

[hyper al] 18/5/2017 09:36

Surely disclosure via conferences and publication protects their intellectual ownership of the knowledge/process. It also promotes the company which could help funding in the future.

This is the usual process for R&D in a biotech, and particularly if projects are also supported by funds from trusts, universities and government grants.

How many investors would complain if there was no news?

[audigger] 18/5/2017 09:01

The last two points are exactly where I'm coming from. To justify the cost and the potential risks of premature disclosure there needs to be a tangible upside. I see more risk than benefit at this stage of the development cycle. Are they touting for new investment? If not, then keep stump and crack on until the next development milestone.

[deutsch3] 18/5/2017 08:51

Sounds like we are funding research and trips to Canada etc. - What is happening to the product? - Meantime someone is bailing out , the management must know and they are saying nothing??

[dogwalker] 18/5/2017 08:38

I say ' keep the cutting-edge science to yourelf, Dr Corteling, until such time as you present it in support of an announcement demonstrating its commercial success & value to its owners. Otherwise, it amounts to unwelcome grandstanding , & disclosure of the company's technical advantage'.

[verger] 18/5/2017 08:00

2018 seems to be the year when RENE will start motoring when results from their Phase III study with CTX cell therapy in stroke disability start coming through. Phase III will start in the second half of this year. It all depends when an investor decides to take a position. I'm already in and waiting.

[fredd1eboy] 18/5/2017 07:46

Looks like they cannot win on this blog site.
Critised for too much pr and same for not enough.
Cannot investors get their head round the facts...
All drug lines moving on well..
Sp = cash in the bank.
There will be plenty of news coming soon, hopefully enough to satisfy the doubting Thomase's

[small crow] 18/5/2017 07:29

I would have said the opposite - this is cutting-edge science.

[audigger] 18/5/2017 07:23

Still weighing-up when best to get in to these. They seem PR-obsessed which makes you wonder why?